BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7005333)

  • 1. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
    Nacy CA; Leonard EJ; Meltzer MS
    J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi.
    Nacy CA; Meltzer MS
    J Immunol; 1979 Dec; 123(6):2544-9. PubMed ID: 115917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-GuĂ©rin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.
    Nacy CA; Meltzer MS; Leonard EJ; Wyler DJ
    J Immunol; 1981 Dec; 127(6):2381-6. PubMed ID: 7299130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
    [No Abstract]   [Full Text] [Related]  

  • 8. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
    Nacy CA; Meltzer MS; Fortier AH
    J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune interferon. I. Production by lymphokine-activated murine macrophages.
    Neumann C; Sorg C
    Eur J Immunol; 1977 Oct; 7(10):719-25. PubMed ID: 338310
    [No Abstract]   [Full Text] [Related]  

  • 14. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
    Poste G
    Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes.
    Oster CN; Nacy CA
    J Immunol; 1984 Mar; 132(3):1494-500. PubMed ID: 6363544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular weight, isoelectric point, and stability of a murine lymphokine that induces macrophage tumoricidal activity.
    Yamamoto S; Leonard EJ; Meltzer M
    J Reticuloendothel Soc; 1983 May; 33(5):343-51. PubMed ID: 6341579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages.
    Bout DT; Joseph M; David JR; Capron AR
    J Immunol; 1981 Jul; 127(1):1-5. PubMed ID: 7240738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages as cytotoxic effector cells.
    Lohmann-Matthes ML; Lang H; Sun D
    Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
    Taffet SM; Pace JL; Russell SW
    J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.